Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multicenter Phase III Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.

NCT01969877 is registered in ClinicalTrials.gov with Lund University Hospital as lead sponsor.

NCT NCT01969877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01969877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multicenter Phase III Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
Lead sponsor
Lund University Hospital
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
April 30, 2018
Enrollment
298 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced head and neck cancer